BiPAP呼吸机治疗急性重症哮喘的临床疗效分析以及探究  

Analysis and Exploration of the Clinical Efficacy of BiPAP Ventilator in the Treatment of Acute Severe Asthma

作　　者：杨菊华 YANG Ju-hua(The Second People's Hospital of Jiulongpo District,Chongqing,Chongqing 400042)

机构地区：[1]重庆市九龙坡区第二人民医院,重庆400042

出　　处：《中国医疗器械信息》2021年第8期151-153,共3页China Medical Device Information

摘　　要：目的:研究BiPAP呼吸机治疗急性重症哮喘的临床疗效。方法:选取本院自2018年11月~2020年3月接诊的120例急性重症哮喘患者,按照随机数字表法将其均分为对照组与实验组,对照组给予常规治疗,实验组在常规治疗基础上增加BiPAP呼吸机进行联合治疗,对比两组临床治疗效果。结果:实验组患者气血指标、肺功能均明显优于对照组,实验组患者肺功能改善时间及哮喘病症控制时间均明显短于对照组,差异有统计学意义(P<0.05)。结论:BiPAP呼吸机治疗急性重症哮喘的临床疗效异常显著。因此,应将BiPAP呼吸机推广至急性重症哮喘病症的临床治疗中,提高临床治疗质量。Objective:To study the clinical efficacy of BiPAP ventilator in the treatment of acute severe asthma.Methods:120 patients with acute severe asthma received in our hospital from November 2018 to March 2020 were divided into the control group and the experimental group according to the random number table method.The control group was given conventional treatment,and the experimental group was added with BiPAP ventilator on the basis of conventional treatment for combined treatment,and the clinical treatment effect of the two groups was compared.Results:The qi and blood indexes and lung function of the experimental group were significantly better than those of the control group,and the improvement time of lung function and asthma symptom control time of the experimental group were significantly shorter than those of the control group,with statistically significant differences(P<0.05).Conclusion:BiPAP ventilator has a remarkable clinical effect on acute severe asthma.Therefore,BiPAP ventilator should be extended to the clinical treatment of acute severe asthma to improve the quality of clinical treatment.

关 键 词：BIPAP呼吸机 急性重症哮喘 临床疗效 

分 类 号：R562.25[医药卫生—呼吸系统]